Global EEG, EMG and Evoked Potential Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 158108
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 122
  • list Medical Devices

Electroencephalogram (EEG) is used to diagnose brain disorders and visualizes the activity of the brain during a seizure. EEG evaluates people who are suffering from brain problems such as coma, confusions and tumors, difficulties in thinking and memory and weakening of specific parts of the body. Electromyography (EMG) measures the electrical activity of muscles at the time of rest and contraction. An EMG uses tiny devices called electrodes which help in transmission and detection of electrical signals. Evoked Potential devices are used to clinically diagnose a wide variety of central nervous system (CNS) diseases.

Scope of the Report:

This report focuses on the EEG, EMG and Evoked Potential Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

In Europe, Germany, Italy, the U.K. and France holds major share of EEG, EMG and Evoked Potential devices market. However, Asia is expected to show high growth rates in the next five years in global EEG, EMG and Evoked Potential devices market. This is due to many companies constructing their R&D facilities in the region. In addition, increasing awareness about various neurological diseases is also supporting in the growth of EEG, EMG and Evoked Potential devices market in the region. Japan, China and India are expected to be the fastest growing EEG, EMG and Evoked Potential devices markets in Asia.

The worldwide market for EEG, EMG and Evoked Potential Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Cadwell Laboratories, Inc. (US)

Compumedics Limited (Australia)

EB Neuro S.P.A. (Italy)

Electrical Geodesics, Inc. (US)

Lifelines Neurodiagnostic Systems, Inc. (US)

Natus Medical Incorporated (US)

NeuroWave Systems, Inc. (US)

Nihon Kohden Corporation (Japan)

Nihon Kohden America, Inc. (US)

Noraxon U.S.A., Inc. (US)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Electroencephalography (EEG)

Electromyography (EMG)

Evoked Potential

Market Segment by Applications, can be divided into

Infections

Head Injuries

Coma and Brain Death

Metabolic Disorders

Cerebrovascular Disorders

There are 15 Chapters to deeply display the global EEG, EMG and Evoked Potential Devices market.

Chapter 1, to describe EEG, EMG and Evoked Potential Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of EEG, EMG and Evoked Potential Devices, with sales, revenue, and price of EEG, EMG and Evoked Potential Devices, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of EEG, EMG and Evoked Potential Devices, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, EEG, EMG and Evoked Potential Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe EEG, EMG and Evoked Potential Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 EEG, EMG and Evoked Potential Devices Introduction

1.2 Market Analysis by Type

1.2.1 Electroencephalography (EEG)

1.2.2 Electromyography (EMG)

1.2.3 Evoked Potential

1.3 Market Analysis by Applications

1.3.1 Infections

1.3.2 Head Injuries

1.3.3 Coma and Brain Death

1.3.4 Metabolic Disorders

1.3.5 Cerebrovascular Disorders

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Cadwell Laboratories, Inc. (US)

2.1.1 Business Overview

2.1.2 EEG, EMG and Evoked Potential Devices Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Cadwell Laboratories, Inc. (US) EEG, EMG and Evoked Potential Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Compumedics Limited (Australia)

2.2.1 Business Overview

2.2.2 EEG, EMG and Evoked Potential Devices Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Compumedics Limited (Australia) EEG, EMG and Evoked Potential Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 EB Neuro S.P.A. (Italy)

2.3.1 Business Overview

2.3.2 EEG, EMG and Evoked Potential Devices Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 EB Neuro S.P.A. (Italy) EEG, EMG and Evoked Potential Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Electrical Geodesics, Inc. (US)

2.4.1 Business Overview

2.4.2 EEG, EMG and Evoked Potential Devices Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Electrical Geodesics, Inc. (US) EEG, EMG and Evoked Potential Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Lifelines Neurodiagnostic Systems, Inc. (US)

2.5.1 Business Overview

2.5.2 EEG, EMG and Evoked Potential Devices Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Lifelines Neurodiagnostic Systems, Inc. (US) EEG, EMG and Evoked Potential Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Natus Medical Incorporated (US)

2.6.1 Business Overview

2.6.2 EEG, EMG and Evoked Potential Devices Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Natus Medical Incorporated (US) EEG, EMG and Evoked Potential Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 NeuroWave Systems, Inc. (US)

2.7.1 Business Overview

2.7.2 EEG, EMG and Evoked Potential Devices Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 NeuroWave Systems, Inc. (US) EEG, EMG and Evoked Potential Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Nihon Kohden Corporation (Japan)

2.8.1 Business Overview

2.8.2 EEG, EMG and Evoked Potential Devices Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Nihon Kohden Corporation (Japan) EEG, EMG and Evoked Potential Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Nihon Kohden America, Inc. (US)

2.9.1 Business Overview

2.9.2 EEG, EMG and Evoked Potential Devices Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Nihon Kohden America, Inc. (US) EEG, EMG and Evoked Potential Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Noraxon U.S.A., Inc. (US)

2.10.1 Business Overview

2.10.2 EEG, EMG and Evoked Potential Devices Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Noraxon U.S.A., Inc. (US) EEG, EMG and Evoked Potential Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global EEG, EMG and Evoked Potential Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global EEG, EMG and Evoked Potential Devices Sales and Market Share by Manufacturer (2016-2017)

3.2 Global EEG, EMG and Evoked Potential Devices Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 EEG, EMG and Evoked Potential Devices Manufacturer Market Share in 2017

3.3.2 Top 6 EEG, EMG and Evoked Potential Devices Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global EEG, EMG and Evoked Potential Devices Market Analysis by Regions

4.1 Global EEG, EMG and Evoked Potential Devices Sales, Revenue and Market Share by Regions

4.1.1 Global EEG, EMG and Evoked Potential Devices Sales and Market Share by Regions (2013-2018)

4.1.2 Global EEG, EMG and Evoked Potential Devices Revenue and Market Share by Regions (2013-2018)

4.2 North America EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

4.3 Europe EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

4.5 South America EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

5 North America EEG, EMG and Evoked Potential Devices by Countries

5.1 North America EEG, EMG and Evoked Potential Devices Sales, Revenue and Market Share by Countries

5.1.1 North America EEG, EMG and Evoked Potential Devices Sales and Market Share by Countries (2013-2018)

5.1.2 North America EEG, EMG and Evoked Potential Devices Revenue and Market Share by Countries (2013-2018)

5.2 United States EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

5.3 Canada EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

5.4 Mexico EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

6 Europe EEG, EMG and Evoked Potential Devices by Countries

6.1 Europe EEG, EMG and Evoked Potential Devices Sales, Revenue and Market Share by Countries

6.1.1 Europe EEG, EMG and Evoked Potential Devices Sales and Market Share by Countries (2013-2018)

6.1.2 Europe EEG, EMG and Evoked Potential Devices Revenue and Market Share by Countries (2013-2018)

6.2 Germany EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

6.3 UK EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

6.4 France EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

6.5 Russia EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

6.6 Italy EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

7 Asia-Pacific EEG, EMG and Evoked Potential Devices by Countries

7.1 Asia-Pacific EEG, EMG and Evoked Potential Devices Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific EEG, EMG and Evoked Potential Devices Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific EEG, EMG and Evoked Potential Devices Revenue and Market Share by Countries (2013-2018)

7.2 China EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

7.3 Japan EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

7.4 Korea EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

7.5 India EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

7.6 Southeast Asia EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

8 South America EEG, EMG and Evoked Potential Devices by Countries

8.1 South America EEG, EMG and Evoked Potential Devices Sales, Revenue and Market Share by Countries

8.1.1 South America EEG, EMG and Evoked Potential Devices Sales and Market Share by Countries (2013-2018)

8.1.2 South America EEG, EMG and Evoked Potential Devices Revenue and Market Share by Countries (2013-2018)

8.2 Brazil EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

8.3 Argentina EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

8.4 Colombia EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

9 Middle East and Africa EEG, EMG and Evoked Potential Devices by Countries

9.1 Middle East and Africa EEG, EMG and Evoked Potential Devices Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa EEG, EMG and Evoked Potential Devices Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa EEG, EMG and Evoked Potential Devices Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

9.3 UAE EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

9.4 Egypt EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

9.5 Nigeria EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

9.6 South Africa EEG, EMG and Evoked Potential Devices Sales and Growth Rate (2013-2018)

10 Global EEG, EMG and Evoked Potential Devices Market Segment by Type

10.1 Global EEG, EMG and Evoked Potential Devices Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global EEG, EMG and Evoked Potential Devices Sales and Market Share by Type (2013-2018)

10.1.2 Global EEG, EMG and Evoked Potential Devices Revenue and Market Share by Type (2013-2018)

10.2 Electroencephalography (EEG) Sales Growth and Price

10.2.1 Global Electroencephalography (EEG) Sales Growth (2013-2018)

10.2.2 Global Electroencephalography (EEG) Price (2013-2018)

10.3 Electromyography (EMG) Sales Growth and Price

10.3.1 Global Electromyography (EMG) Sales Growth (2013-2018)

10.3.2 Global Electromyography (EMG) Price (2013-2018)

10.4 Evoked Potential Sales Growth and Price

10.4.1 Global Evoked Potential Sales Growth (2013-2018)

10.4.2 Global Evoked Potential Price (2013-2018)

11 Global EEG, EMG and Evoked Potential Devices Market Segment by Application

11.1 Global EEG, EMG and Evoked Potential Devices Sales Market Share by Application (2013-2018)

11.2 Infections Sales Growth (2013-2018)

11.3 Head Injuries Sales Growth (2013-2018)

11.4 Coma and Brain Death Sales Growth (2013-2018)

11.5 Metabolic Disorders Sales Growth (2013-2018)

11.6 Cerebrovascular Disorders Sales Growth (2013-2018)

12 EEG, EMG and Evoked Potential Devices Market Forecast (2018-2023)

12.1 Global EEG, EMG and Evoked Potential Devices Sales, Revenue and Growth Rate (2018-2023)

12.2 EEG, EMG and Evoked Potential Devices Market Forecast by Regions (2018-2023)

12.2.1 North America EEG, EMG and Evoked Potential Devices Market Forecast (2018-2023)

12.2.2 Europe EEG, EMG and Evoked Potential Devices Market Forecast (2018-2023)

12.2.3 Asia-Pacific EEG, EMG and Evoked Potential Devices Market Forecast (2018-2023)

12.2.4 South America EEG, EMG and Evoked Potential Devices Market Forecast (2018-2023)

12.2.5 Middle East and Africa EEG, EMG and Evoked Potential Devices Market Forecast (2018-2023)

12.3 EEG, EMG and Evoked Potential Devices Market Forecast by Type (2018-2023)

12.3.1 Global EEG, EMG and Evoked Potential Devices Sales Forecast by Type (2018-2023)

12.3.2 Global EEG, EMG and Evoked Potential Devices Market Share Forecast by Type (2018-2023)

12.4 EEG, EMG and Evoked Potential Devices Market Forecast by Application (2018-2023)

12.4.1 Global EEG, EMG and Evoked Potential Devices Sales Forecast by Application (2018-2023)

12.4.2 Global EEG, EMG and Evoked Potential Devices Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure EEG, EMG and Evoked Potential Devices Picture

Table Product Specifications of EEG, EMG and Evoked Potential Devices

Figure Global Sales Market Share of EEG, EMG and

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery